Connor, Clark & Lunn Investment Management Ltd. Trillium Therapeutics Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $20 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
N/A
-20,200 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
N/A
-322,300 Reduced 94.1%
20,200 $355,000
Q2 2021

Aug 12, 2021
SELL
N/A
-27,400 Reduced 7.41%
342,500 $3.32 Million
Q1 2021

May 13, 2021
BUY
N/A
169,400 Added 84.49%
369,900 $3.96 Million
Q4 2020

Feb 16, 2021
BUY
N/A
200,500 New
200,500 $2.95 Million

About Trillium Therapeutics Inc.

TRIL Quotes by TradingView
  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email